NovioSense is a new type of glucose sensor. It is a non-invasive, wireless sensor to continuously monitor glucose levels in tear fluid to enhance care and treatment of diabetes patients. The sensor enables the introduction of new medical device systems to improve the glucose management of diabetes patients and thus to significantly improve the quality of life of people living with diabetes.
Inventors of the patented (pending) technology are Hans Hanssen and Rob Tweehuysen, founders and directors of NovioTech BV, an accelerator for such developments.
For further information about the NovioSense glucose sensor see their website and click here.